Exelixis
EXEL
#2017
Rank
A$12.12 B
Marketcap
$42.19
Share price
-0.85%
Change (1 day)
27.34%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company